Numerous people in Britain are experiencing a puzzling and severe skin disorder that has left the medical profession baffled. Sufferers experience their skin badly inflamed, cracked and flaking, often across their entire bodies, yet many doctors struggle to diagnose or treat the condition. The condition, called topical steroid withdrawal (TSW) or red skin syndrome, has generated significant attention on online platforms, with clips featuring patients’ experiences garnering over a billion views on TikTok alone. Despite affecting a increasing number of people, TSW remains so inadequately understood that some doctors and dermatologists doubt whether it exists at all. Now, for the very first time, researchers in the UK are launching a major study to examine what is responsible for these unexplained symptoms and how some people come to develop the condition whereas others do not.
The Mysterious Condition Spreading Across the UK
Bethany Gamble’s story exemplifies the devastating impact of topical steroid withdrawal on those affected. The 21-year-old from Birmingham had controlled her eczema successfully with steroid creams since childhood, but at eighteen, her condition deteriorated significantly. Her skin became severely inflamed and reddened, breaking and leaking whilst the itching became what she refers to as “bone deep”. Within two years, the pain had become so acute that she was stuck in her bed, requiring round-the-clock care from her mother. Most troubling, Bethany was repeatedly dismissed by medical professionals who attributed her symptoms to standard eczema and continued prescribing the very treatments she thought were responsible for her suffering.
The medical community remains divided on how to approach TSW, with significant discord about its very nature. Some experts consider it a severe allergic response to the topical steroids that serve as the primary treatment for eczema across the NHS. Others argue it represents a serious exacerbation of current skin conditions rather than a separate syndrome, whilst a small number are sceptical of its existence. This clinical uncertainty has put patients like Bethany trapped in a diagnostic uncertainty, having difficulty accessing suitable treatment. The lack of consensus has encouraged Professor Sara Brown at the Edinburgh University to establish the first significant UK research initiative studying TSW, funded by the National Eczema Society.
- Symptoms involve significant swelling, cracking skin and persistent pruritus throughout the body
- Patients report “elephant skin” hardening and extreme shedding of keratinised cells
- Medical professionals frequently overlook TSW as standard eczema or refuse to acknowledge it
- The condition may prove so debilitating that sufferers find themselves unable to perform daily activities
Living with Steroid Topical Withdrawal
From Controllable Eczema to Debilitating Symptoms
For many patients, topical steroid withdrawal represents a catastrophic deterioration from a previously stable dermatological condition. What starts with intermittent itching in skin creases can rapidly escalate into a full-body inflammatory response that renders patients unable to function. The change typically happens abruptly, unexpectedly, converting a controllable long-term condition into an severe medical emergency. Patients report their skin becoming impossibly hot, inflamed and red, with severe cracking and oozing that demands constant attention. The bodily burden is compounded by exhaustion, as the relentless itching disrupts sleep and healing, creating a destructive cycle of decline.
The speed at which TSW progresses catches many sufferers by surprise. Those who have experienced eczema for years, sometimes decades, are unprepared for the intensity of symptoms that develop when their condition rapidly deteriorates. Everyday tasks become formidable obstacles: showering becomes excruciating, dressing demands help, and preserving hygiene demands substantial energy. Some patients describe feeling as though their skin is being ravaged from within, with inflammation extending over their body in patterns that show little similarity to their earlier flare-ups. This dramatic transformation often drives sufferers to obtain emergency care, only to encounter scepticism from healthcare professionals.
The Fight for Recognition
Perhaps the cruelest aspect of topical steroid withdrawal is the medical gaslighting that commonly occurs with it. Patients experiencing severe, unexplained symptoms are routinely told they merely suffer from eczema flaring up, despite their assertion that this is fundamentally different from anything they’ve encountered previously. Doctors often respond by recommending higher-strength steroids or increased doses, possibly exacerbating the very condition patients believe the creams caused. This cycle of dismissal leaves sufferers feeling abandoned by the healthcare system, forced to navigate their illness alone whilst being informed that their personal experience lacks validity. Many patients report experiencing repeated invalidation, their concerns dismissed as emotional or psychological in nature rather than actual physical health issues.
The lack of medical consensus has created a significant divide between what patients report and clinical acknowledgement. Without established diagnostic standards or established treatment protocols, GPs and dermatologists struggle to identify TSW or offer appropriate support. Some clinicians remain completely sceptical the disorder is real, treating all acute cases as standard eczema or recognised skin disorders. This clinical doubt translates into diagnostic delays, inappropriate treatment and profound psychological distress for patients already suffering physically. The growing visibility of TSW on social media has drawn attention to this diagnostic void, prompting researchers to investigate what thousands of people claim to be experiencing, even as the medical establishment continues to disagree on the appropriate response.
- Symptoms can emerge suddenly in individuals with previously stable eczema treated by steroid creams
- Patients often face disbelief from medical practitioners who attribute deterioration to standard eczema flares
- Healthcare providers continue to disagree on whether TSW is a genuine condition or acute eczema flare-up
- Absence of diagnostic criteria means many sufferers find it difficult to obtain suitable care and assistance
- Online platforms has amplified patient voices, with TSW hashtags reaching over a billion views worldwide
Racial Inequities in Diagnosis and Care
The diagnostic challenges surrounding TSW become increasingly evident amongst those with darker complexions, where symptoms can be substantially more challenging to detect visually. Redness and inflammation, the characteristic indicators of TSW in those with lighter complexions, present distinctly across multiple populations, yet many assessment protocols remain centred on how the condition appears in white patients. This gap means that Black, Asian and other people of colour experiencing TSW often face substantially longer periods in acknowledgement and confirmation. Healthcare professionals trained chiefly via presentations in lighter skin may fail to recognise the defining features, leading to continued misidentification and incorrect management approaches that can worsen symptoms.
Research into TSW has traditionally overlooked the experiences of people with deeper skin tones, sustaining a pattern where their symptoms remain under-documented and under-studied. The social media conversations shaping TSW discourse have been largely shaped by voices with lighter skin, risking distortion of medical understanding and community understanding. As Professor Sara Brown’s groundbreaking UK study advances, ensuring diverse representation amongst participants will be crucial to developing truly inclusive diagnostic frameworks and therapeutic strategies. Without intentional action to centre the experiences of all ethnic groups, treatment inequalities in TSW identification and care threaten to increase, leaving vulnerable populations without adequate support or answers.
| Skin Tone | TSW Appearance |
|---|---|
| Light/Fair | Bright red inflammation, visible flushing and erythema across affected areas |
| Medium/Olive | Darker red or brownish discolouration with less pronounced visible redness |
| Dark/Deep | Purple-toned or ashen discolouration, with inflammation appearing as hyperpigmentation or hypopigmentation |
| Very Dark | Subtle changes in skin texture and tone, with inflammation manifesting as dark patches or loss of pigmentation |
Research and Treatment Options Coming to Light
First Major UK Study Currently Happening
Professor Sara Brown’s landmark research at the Edinburgh University represents a significant milestone for TSW sufferers seeking validation and clarity. With backing from the National Eczema Society, the study has brought together hundreds of participants across the UK to examine the physiological processes behind topical steroid withdrawal. By examining symptoms, saliva samples and skin biopsies, researchers aim to identify why particular individuals exhibit TSW whilst others using identical steroid regimens do not. This rigorous investigation marks a significant shift from dismissal to thorough inquiry.
The study team working alongside Dr Alice Burleigh from patients’ support organisation Scratch That, brings both medical knowledge and firsthand experience to the investigation. Their joint methodology acknowledges that patients themselves hold essential understanding into their medical conditions. Professor Brown has noted patterns in TSW that defy explanation by standard eczema knowledge, including characteristic “elephant skin” thickening, severe shedding and distinctly marked zones of inflammation. The study results could significantly transform how healthcare practitioners approach diagnosis and management of this serious condition.
Available Treatments and Their Limitations
Presently, management options for TSW remain limited and commonly disappointing. Many healthcare professionals continue prescribing topical steroids despite evidence indicating they could worsen symptoms in those predisposed. Some patients note transient relief from moisturisers, antihistamines and systemic drugs, though results vary widely. Dermatologists remain divided on optimal management strategies, with some supporting total steroid discontinuation whilst others advocate phased withdrawal. This shortage of unified guidance forces patients to navigate their treatment journeys largely alone, drawing substantially on peer support networks and web-based forums for guidance.
Psychological support and specialist dermatological care offer potential benefits, yet access is inconsistent across the NHS. Some patients have investigated complementary methods including changes to diet, environmental controls and holistic therapies, though scientific evidence supporting these interventions is limited. The lack of established clinical protocols means treatment decisions frequently rely upon individual dermatologist experience and patient preference rather than evidence-based guidelines. Until robust research yields conclusive findings, TSW sufferers frequently describe experiencing abandonment by conventional medicine.
- Emollient creams and hydrating products to enhance the skin’s protective barrier and decrease water loss
- Antihistamines to control itching and related sleep disruption during flare-ups
- Systemic corticosteroids or immunosuppressants for serious presentations with specialist oversight
- Therapeutic counselling to tackle trauma and anxiety stemming from prolonged skin suffering
Sounds of Optimism and Resolve
Despite the uncertainty surrounding TSW and the often dismissive attitudes from healthcare professionals, patients are finding strength in community and shared experience. Online support networks have emerged as lifelines for those contending with the disorder, offering validation and practical advice when conventional medicine has let them down. Many individuals affected recount the moment they discovered the TSW hashtag as transformative—finally connecting with others with the same symptoms and recognising they were not isolated in their experience. This unified voice has been powerful enough to spark the first serious research efforts, showing that patient-led campaigns can advance medical understanding even when established institutions stay unconvinced.
Bethany Gamble and those facing comparable challenges are determined to raise awareness and advocate for due recognition of TSW within the medical establishment. Their readiness to recount personal stories of their difficulties on social media has normalised conversations around a disorder that various medical professionals still are unwilling to accept. These individuals are not sitting idly for answers; they are taking part in scientific investigations, tracking their signs carefully, and insisting that their experiences be given proper consideration. Their determination in the midst of ongoing pain and medical gaslighting provides encouragement that solutions could become within attainment, and that future patients will be given the acknowledgement and treatment they urgently require.
- Patient-led research initiatives are filling gaps overlooked by conventional healthcare systems and advancing knowledge of TSW
- Digital support networks offer emotional support, practical coping strategies, and mutual recognition for affected individuals worldwide
- Advocacy efforts are incrementally changing medical perception, encouraging dermatologists to examine rather than overlook individual accounts
